Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China · Delayed Price · Currency is CNY 13.98
+0.79 (5.99%)
Aug 4, 2026, 3:00 PM CST
SHA:688488 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 503.95 | 371.16 | 335.34 | 225.36 | 134.91 | 442.71 |
Trading Asset Securities | 30.11 | 80.19 | 106.18 | 215.75 | 351.64 | 163.31 |
Cash & Short-Term Investments | 534.06 | 451.35 | 441.52 | 441.1 | 486.54 | 606.02 |
Cash Growth | 17.93% | 2.23% | 0.10% | -9.34% | -19.71% | -22.41% |
Accounts Receivable | 199.57 | 200.91 | 162.92 | 207.62 | 134.74 | 89.68 |
Other Receivables | 7.19 | 0.01 | 0.03 | 0.01 | - | - |
Receivables | 206.77 | 200.92 | 162.96 | 207.64 | 134.74 | 89.68 |
Inventory | 257.92 | 259.49 | 254.97 | 184.88 | 156.15 | 114.27 |
Other Current Assets | 13.95 | 26.98 | 35.48 | 38.76 | 25.02 | 16.97 |
Total Current Assets | 1,013 | 938.74 | 894.93 | 872.38 | 802.46 | 826.93 |
Property, Plant & Equipment | 402.47 | 404.26 | 434.45 | 443.54 | 447.18 | 327.3 |
Long-Term Investments | 91.6 | 90.82 | 69.6 | 150.88 | 148.81 | 58.2 |
Goodwill | 171.62 | 171.62 | 171.62 | 13.24 | 13.24 | 13.24 |
Other Intangible Assets | 149.71 | 154.64 | 175.47 | 114.59 | 117.62 | 128.23 |
Long-Term Deferred Tax Assets | 84.65 | 83.73 | 83.85 | 54.29 | 39.02 | 19.32 |
Long-Term Deferred Charges | 72.99 | 65.83 | 36.41 | 83.9 | 69.13 | 42.94 |
Other Long-Term Assets | 73.15 | 2.97 | 3.24 | 13.74 | 18.09 | 18.45 |
Total Assets | 2,059 | 1,913 | 1,870 | 1,747 | 1,656 | 1,435 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 85.96 | 51.97 | 57.67 | 35.67 | 27.34 | 28.1 |
Accrued Expenses | 15.86 | 77.57 | 61.93 | 39.2 | 35.11 | 20.11 |
Short-Term Debt | 428.11 | 365.18 | 220.5 | 255.55 | 145.16 | - |
Current Portion of Long-Term Debt | 52.91 | 116.41 | 169.05 | 80.07 | 0.07 | - |
Current Portion of Leases | - | 2.16 | 4.22 | 3.78 | 2.05 | 4.23 |
Current Income Taxes Payable | 8.44 | 0.82 | 0.82 | - | - | - |
Current Unearned Revenue | 6.6 | 5.22 | 13.08 | 6.25 | 33.12 | 2.43 |
Other Current Liabilities | 77.79 | 89.89 | 121.78 | 71.04 | 88.83 | 37.67 |
Total Current Liabilities | 675.68 | 709.21 | 649.06 | 491.57 | 331.68 | 92.54 |
Long-Term Debt | 231.24 | 71.74 | 90.51 | 69.94 | 60 | - |
Long-Term Leases | 7.66 | 3.67 | 3.75 | 2.96 | 1.5 | 1.36 |
Long-Term Unearned Revenue | 42.96 | 43.76 | 49.74 | 50.29 | 56.37 | 25.05 |
Long-Term Deferred Tax Liabilities | 11.72 | 11 | 9.43 | 6.28 | 7.02 | 5.86 |
Total Liabilities | 969.26 | 839.37 | 802.48 | 621.03 | 456.57 | 124.82 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 420.78 | 420.78 | 420.78 | 420.78 | 420 | 420 |
Additional Paid-In Capital | 889.56 | 887.33 | 883.62 | 888.35 | 886.2 | 873.78 |
Retained Earnings | -337.27 | -344.88 | -325.35 | -184.14 | -108.07 | 16.12 |
Comprehensive Income & Other | 1.44 | 1.45 | 1.84 | 0.55 | 0.85 | -0.1 |
Total Common Equity | 974.51 | 964.68 | 980.89 | 1,126 | 1,199 | 1,310 |
Minority Interest | 115.12 | 108.55 | 86.19 | - | - | - |
Shareholders' Equity | 1,090 | 1,073 | 1,067 | 1,126 | 1,199 | 1,310 |
Total Liabilities & Equity | 2,059 | 1,913 | 1,870 | 1,747 | 1,656 | 1,435 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 719.92 | 559.15 | 488.03 | 412.3 | 208.77 | 5.59 |
Net Cash (Debt) | -185.85 | -107.8 | -46.5 | 28.8 | 277.78 | 600.43 |
Net Cash Growth | - | - | - | -89.63% | -53.74% | -23.12% |
Net Cash Per Share | -0.44 | -0.26 | -0.11 | 0.07 | 0.67 | 1.40 |
Filing Date Shares Outstanding | 420.78 | 420.78 | 420.78 | 420.78 | 420 | 420 |
Total Common Shares Outstanding | 420.78 | 420.78 | 420.78 | 420.78 | 420 | 420 |
Working Capital | 337.02 | 229.53 | 245.87 | 380.81 | 470.78 | 734.39 |
Book Value Per Share | 2.32 | 2.29 | 2.33 | 2.67 | 2.85 | 3.12 |
Tangible Book Value | 653.18 | 638.42 | 633.81 | 997.71 | 1,068 | 1,168 |
Tangible Book Value Per Share | 1.55 | 1.52 | 1.51 | 2.37 | 2.54 | 2.78 |
Buildings | - | 393.38 | 393.46 | 375.44 | 344.92 | 217.76 |
Machinery | - | 264.3 | 260.49 | 221.21 | 198.6 | 125.31 |
Construction In Progress | - | - | 2.18 | 3.12 | 36.82 | 95.23 |